Sodium Iodide → HCID 57717624, compound
Reaction equation
Cl[CH2:2][CH2:3][CH2:4][CH2:5][C:6]1[N:7]([CH2:20][CH2:21][O:22][CH3:23])[N:8]=[C:9]2[C:18]=1[C:17]1[CH:16]=[CH:15][CH:14]=[CH:13][C:12]=1[N:11]=[C:10]2[NH2:19].[CH3:24][S:25]([NH2:28])(=[O:27])=[O:26].[H-].[Na+].[I-].[Na+]>>[NH2:19][C:10]1[C:9]2=[N:8][N:7]([CH2:20][CH2:21][O:22][CH3:23])[C:6]([CH2:5][CH2:4][CH2:3][CH2:2][NH:28][S:25]([CH3:24])(=[O:27])=[O:26])=[C:18]2[C:17]2[CH:16]=[CH:15][CH:14]=[CH:13][C:12]=2[N:11]=1Participants
5
Procedure
The method described in Example 1254 was used to treat 1-(4-chlorobutyl)-2-(2-methoxyethyl)-2H-pyrazolo[3,4-c]quinolin-4-amine (1.1 g, 3.3 mmol) with methanesulfonamide pretreated with sodium hydride in the presence of sodium iodide. The crude was purified by chromatography using a HORIZON HPFC system (40+M cartridge, eluting with 0-30% CMA in chloroform) followed by recrystallization from acetonitrile to provide 600 mg of N-{4-[4-amino-2-(2-methoxyethyl)-2H-pyrazolo[3,4-c]quinolin-1-yl]butyl}methanesulfonamide as white crystals, mp 159-161° C.
Workup
- customThe crude was purified by chromatography
- washa HORIZON HPFC system (40+M cartridge, eluting with 0-30% CMA in chloroform)
- customfollowed by recrystallization from acetonitrile
Sources & evidence
- ORD record
- ord-345fb54499e1498fbd250de7cc0212a1
- Source dataset
- uspto-grants-2011_02
- Patent number
- US07879849B2
Reaction notes
Loading…